Page 7 - Contract Testing News Today : Breaking News, Live Updates & Top Stories | Vimarsana

TESSA™ technology provides a scalable process for manufacturing gene therapies, accelerating the production of large quantities of therapeutic DNA required to treat patients in need New data published in Nature Communications supports the benefits of this technology PHILADELPHIA, March 8, 2022 /PRNewswire/ -- WuXi Advanced Therapies (WuXi ATU), a wholly owned subsidiary of WuXi AppTec, today announced the launch...

When tests are hard to write, they are telling you how the production design can be improved. Unit Testing offers priceless feedback if only you'd listen.

Merck KGaA (MKGAF) announced organizational changes and a new operating model for its growth strategy.Existing Contract Development and Manufacturing Organization ((CDMO)) and...

DARMSTADT, Germany, Feb. 7, 2022 /PRNewswire/ -- MilliporeSigma, the U.S. and Canada Life Science business of Merck KGaA, Darmstadt, Germany, a le...

Press release content from PR Newswire. The AP news staff was not involved in its creation.